Neurohormones, cytokines and programmed cell death in heart failure: a new paradigm for the remodeling heart.
Valgimigli
M
M
University of Ferrara, Cardiology and Intensive Cardiology Care Unit, S. Anna Hospital, Italy. mvalgim@tin.it
Curello
S
S
Ceconi
C
C
Agnoletti
L
L
Comini
L
L
Bachetti
T
T
Merli
E
E
Ferrari
R
R
D000110:Acetylcholinesterase / Q000378:metabolism; D000809:Angiotensins / Q000378:metabolism; D017209:Apoptosis / Q000502:physiology*; D016207:Cytokines / Q000502:physiology*; D016232:Endothelins / Q000378:metabolism; D006321:Heart / Q000502:physiology / Q000503:physiopathology; D006333:Heart Failure / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000503:physiopathology; D009203:Myocardial Infarction / Q000209:etiology / Q000503:physiopathology; D009206:Myocardium / Q000473:pathology; D018377:Neurotransmitter Agents / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000503:physiopathology; D020257:Ventricular Remodeling / Q000502:physiology
D000809:Angiotensins; D016207:Cytokines; D016232:Endothelins; D018377:Neurotransmitter Agents; D000110:Acetylcholinesterase